Splenic regression of amyloid on multi-modality imaging in response to treatment with patisiran and diflunisal in hereditary transthyretin amyloidosis

Amyloid. 2021 Dec;28(4):269-270. doi: 10.1080/13506129.2021.1920389. Epub 2021 May 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloid Neuropathies, Familial* / diagnostic imaging
  • Amyloid Neuropathies, Familial* / drug therapy
  • Diflunisal*
  • Humans
  • Multimodal Imaging
  • Prealbumin / genetics
  • RNA, Small Interfering

Substances

  • Prealbumin
  • RNA, Small Interfering
  • patisiran
  • Diflunisal

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related